APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Microbial Alternative Protein

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Microbial Alternative Protein Industry Growth and Trends Forecast to 2032

Report ID 174496530213 August 202697 pages

Choose your research edition.

Industry ResearchMicrobial Alternative Protein Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Microbial Alternative Protein Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Microbial Alternative Protein Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Microbial Alternative Protein Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Microbial Alternative Protein Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Microbial Alternative Protein market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Microbial Alternative Protein is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Microbial Alternative Protein is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Microbial Alternative Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Microbial Alternative Protein include AgriProtein (South Africa), Ynsect (France), Enterra Feed Corporation (Canada), Protix (The Netherlands), Proti-Farm Holding NV (The Netherlands), Entomo Farms (Canada), Global Bugs Asia Co., Ltd. (Thailand), Aspire Food Group (U.S.) and Tiny Farms (U.S.), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Microbial Alternative Protein market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Microbial Alternative Protein market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Microbial Alternative Protein market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Microbial Alternative Protein.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Microbial Alternative Protein market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Microbial Alternative Protein Market by Company

AgriProtein (South Africa)

Ynsect (France)

Enterra Feed Corporation (Canada)

Protix (The Netherlands)

Proti-Farm Holding NV (The Netherlands)

Entomo Farms (Canada)

Global Bugs Asia Co., Ltd. (Thailand)

Aspire Food Group (U.S.)

Tiny Farms (U.S.)

Microbial Alternative Protein Segment by Type

Yeast Protein

Microalgae Protein

Bacterial Protein

Other

Microbial Alternative Protein Segment by Application

Food

Feed

Others

Microbial Alternative Protein Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microbial Alternative Protein market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Microbial Alternative Protein and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microbial Alternative Protein.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Microbial Alternative Protein manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Microbial Alternative Protein in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Yeast Protein Table 2. Major Company of Microalgae Protein Table 3. Major Company of Bacterial Protein Table 4. Major Company of Other Table 5. Global Microbial Alternative Protein Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Microbial Alternative Protein Sales by Type (2021-2026) & (k units) Table 7. Global Microbial Alternative Protein Sales Market Share in Volume by Type (2021-2026) Table 8. Global Microbial Alternative Protein Sales by Type (2021-2026) & (US$ Million) Table 9. Global Microbial Alternative Protein Sales Market Share in Value by Type (2021-2026) Table 10. Global Microbial Alternative Protein Price by Type (2021-2026) & (USD/unit) Table 11. Global Microbial Alternative Protein Sales by Type (2027-2032) & (k units) Table 12. Global Microbial Alternative Protein Sales Market Share in Volume by Type (2027-2032) Table 13. Global Microbial Alternative Protein Sales by Type (2027-2032) & (US$ Million) Table 14. Global Microbial Alternative Protein Sales Market Share in Value by Type (2027-2032) Table 15. Global Microbial Alternative Protein Price by Type (2027-2032) & (USD/unit) Table 16. North America Microbial Alternative Protein Sales by Type (2021-2026) & (k units) Table 17. North America Microbial Alternative Protein Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Microbial Alternative Protein Sales by Type (2021-2026) & (k units) Table 19. Europe Microbial Alternative Protein Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Microbial Alternative Protein Sales by Type (2021-2026) & (k units) Table 21. Asia-Pacific Microbial Alternative Protein Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Microbial Alternative Protein Sales by Type (2021-2026) & (k units) Table 23. Latin America Microbial Alternative Protein Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Microbial Alternative Protein Sales by Type (2021-2026) & (k units) Table 25. Middle East and Africa Microbial Alternative Protein Sales by Type (2021-2026) & (US$ Million) Table 26. Microbial Alternative Protein Industry Trends Table 27. Microbial Alternative Protein Industry Drivers Table 28. Microbial Alternative Protein Industry Opportunities and Challenges Table 29. Microbial Alternative Protein Industry Restraints Table 30. Global Microbial Alternative Protein Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Microbial Alternative Protein Revenue Market Share by Company (2021-2026) Table 32. Global Microbial Alternative Protein Sales by Company (2021-2026) & (k units) Table 33. Global Microbial Alternative Protein Sales Share by Company (2021-2026) Table 34. Global Microbial Alternative Protein Market Price by Company (2021-2026) & (USD/unit) Table 35. Global Microbial Alternative Protein Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Microbial Alternative Protein Major Company Production Sites and Headquarters Table 37. Global Microbial Alternative Protein Company, Product Type & Application Table 38. Global Microbial Alternative Protein Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Microbial Alternative Protein by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Microbial Alternative Protein Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Microbial Alternative Protein Sales by Region (2021-2026) & (k units) Table 43. Global Microbial Alternative Protein Sales Market Share in Volume by Region (2021-2026) Table 44. Global Microbial Alternative Protein Sales by Region (2021-2026) & (US$ Million) Table 45. Global Microbial Alternative Protein Sales Market Share in Value by Region (2021-2026) Table 46. Global Microbial Alternative Protein Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 47. Global Microbial Alternative Protein Sales by Region (2027-2032) & (k units) Table 48. Global Microbial Alternative Protein Sales Market Share in Volume by Region (2027-2032) Table 49. Global Microbial Alternative Protein Sales by Region (2027-2032) & (US$ Million) Table 50. Global Microbial Alternative Protein Sales Market Share in Value by Region (2027-2032) Table 51. Global Microbial Alternative Protein Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 52. Global Microbial Alternative Protein Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Microbial Alternative Protein Sales by Application (2021-2026) & (k units) Table 54. Global Microbial Alternative Protein Sales Market Share in Volume by Application (2021-2026) Table 55. Global Microbial Alternative Protein Sales by Application (2021-2026) & (US$ Million) Table 56. Global Microbial Alternative Protein Sales Market Share in Value by Application (2021-2026) Table 57. Global Microbial Alternative Protein Price by Application (2021-2026) & (USD/unit) Table 58. Global Microbial Alternative Protein Sales by Application (2027-2032) & (k units) Table 59. Global Microbial Alternative Protein Sales Market Share in Volume by Application (2027-2032) Table 60. Global Microbial Alternative Protein Sales by Application (2027-2032) & (US$ Million) Table 61. Global Microbial Alternative Protein Sales Market Share in Value by Application (2027-2032) Table 62. Global Microbial Alternative Protein Price by Application (2027-2032) & (USD/unit) Table 63. North America Microbial Alternative Protein Sales by Application (2021-2026) & (k units) Table 64. North America Microbial Alternative Protein Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Microbial Alternative Protein Sales by Application (2021-2026) & (k units) Table 66. Europe Microbial Alternative Protein Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Microbial Alternative Protein Sales by Application (2021-2026) & (k units) Table 68. Asia-Pacific Microbial Alternative Protein Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Microbial Alternative Protein Sales by Application (2021-2026) & (k units) Table 70. Latin America Microbial Alternative Protein Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Microbial Alternative Protein Sales by Application (2021-2026) & (k units) Table 72. Middle East and Africa Microbial Alternative Protein Sales by Application (2021-2026) & (US$ Million) Table 73. AgriProtein (South Africa) Company Information Table 74. AgriProtein (South Africa) Business Overview Table 75. AgriProtein (South Africa) Microbial Alternative Protein Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. AgriProtein (South Africa) Microbial Alternative Protein Product Portfolio Table 77. AgriProtein (South Africa) Recent Development Table 78. Ynsect (France) Company Information Table 79. Ynsect (France) Business Overview Table 80. Ynsect (France) Microbial Alternative Protein Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Ynsect (France) Microbial Alternative Protein Product Portfolio Table 82. Ynsect (France) Recent Development Table 83. Enterra Feed Corporation (Canada) Company Information Table 84. Enterra Feed Corporation (Canada) Business Overview Table 85. Enterra Feed Corporation (Canada) Microbial Alternative Protein Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Enterra Feed Corporation (Canada) Microbial Alternative Protein Product Portfolio Table 87. Enterra Feed Corporation (Canada) Recent Development Table 88. Protix (The Netherlands) Company Information Table 89. Protix (The Netherlands) Business Overview Table 90. Protix (The Netherlands) Microbial Alternative Protein Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Protix (The Netherlands) Microbial Alternative Protein Product Portfolio Table 92. Protix (The Netherlands) Recent Development Table 93. Proti-Farm Holding NV (The Netherlands) Company Information Table 94. Proti-Farm Holding NV (The Netherlands) Business Overview Table 95. Proti-Farm Holding NV (The Netherlands) Microbial Alternative Protein Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Proti-Farm Holding NV (The Netherlands) Microbial Alternative Protein Product Portfolio Table 97. Proti-Farm Holding NV (The Netherlands) Recent Development Table 98. Entomo Farms (Canada) Company Information Table 99. Entomo Farms (Canada) Business Overview Table 100. Entomo Farms (Canada) Microbial Alternative Protein Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Entomo Farms (Canada) Microbial Alternative Protein Product Portfolio Table 102. Entomo Farms (Canada) Recent Development Table 103. Global Bugs Asia Co., Ltd. (Thailand) Company Information Table 104. Global Bugs Asia Co., Ltd. (Thailand) Business Overview Table 105. Global Bugs Asia Co., Ltd. (Thailand) Microbial Alternative Protein Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Global Bugs Asia Co., Ltd. (Thailand) Microbial Alternative Protein Product Portfolio Table 107. Global Bugs Asia Co., Ltd. (Thailand) Recent Development Table 108. Aspire Food Group (U.S.) Company Information Table 109. Aspire Food Group (U.S.) Business Overview Table 110. Aspire Food Group (U.S.) Microbial Alternative Protein Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Aspire Food Group (U.S.) Microbial Alternative Protein Product Portfolio Table 112. Aspire Food Group (U.S.) Recent Development Table 113. Tiny Farms (U.S.) Company Information Table 114. Tiny Farms (U.S.) Business Overview Table 115. Tiny Farms (U.S.) Microbial Alternative Protein Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Tiny Farms (U.S.) Microbial Alternative Protein Product Portfolio Table 117. Tiny Farms (U.S.) Recent Development Table 118. North America Microbial Alternative Protein Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 119. North America Microbial Alternative Protein Sales by Country (2021-2026) & (k units) Table 120. North America Microbial Alternative Protein Sales Market Share by Country (2021-2026) Table 121. North America Microbial Alternative Protein Sales Forecast by Country (2027-2032) & (k units) Table 122. North America Microbial Alternative Protein Sales Market Share Forecast by Country (2027-2032) Table 123. North America Microbial Alternative Protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Microbial Alternative Protein Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Microbial Alternative Protein Market Share by Country (2021-2026) Table 126. North America Microbial Alternative Protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Microbial Alternative Protein Market Share Forecast by Country (2027-2032) Table 128. Europe Microbial Alternative Protein Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 129. Europe Microbial Alternative Protein Sales by Country (2021-2026) & (k units) Table 130. Europe Microbial Alternative Protein Sales Market Share by Country (2021-2026) Table 131. Europe Microbial Alternative Protein Sales Forecast by Country (2027-2032) & (k units) Table 132. Europe Microbial Alternative Protein Sales Market Share Forecast by Country (2027-2032) Table 133. Europe Microbial Alternative Protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Microbial Alternative Protein Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Microbial Alternative Protein Market Share by Country (2021-2026) Table 136. Europe Microbial Alternative Protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Microbial Alternative Protein Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Microbial Alternative Protein Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Microbial Alternative Protein Sales by Country (2021-2026) & (k units) Table 140. Asia-Pacific Microbial Alternative Protein Sales Market Share by Country (2021-2026) Table 141. Asia-Pacific Microbial Alternative Protein Sales Forecast by Country (2027-2032) & (k units) Table 142. Asia-Pacific Microbial Alternative Protein Sales Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Microbial Alternative Protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Microbial Alternative Protein Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Microbial Alternative Protein Market Share by Country (2021-2026) Table 146. Asia-Pacific Microbial Alternative Protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Microbial Alternative Protein Market Share Forecast by Country (2027-2032) Table 148. Latin America Microbial Alternative Protein Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 149. Latin America Microbial Alternative Protein Sales by Country (2021-2026) & (k units) Table 150. Latin America Microbial Alternative Protein Sales Market Share by Country (2021-2026) Table 151. Latin America Microbial Alternative Protein Sales Forecast by Country (2027-2032) & (k units) Table 152. Latin America Microbial Alternative Protein Sales Market Share Forecast by Country (2027-2032) Table 153. Latin America Microbial Alternative Protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Microbial Alternative Protein Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Microbial Alternative Protein Market Share by Country (2021-2026) Table 156. Latin America Microbial Alternative Protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Microbial Alternative Protein Market Share Forecast by Country (2027-2032) Table 158. Middle East and Africa Microbial Alternative Protein Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 159. Middle East and Africa Microbial Alternative Protein Sales by Country (2021-2026) & (k units) Table 160. Middle East and Africa Microbial Alternative Protein Sales Market Share by Country (2021-2026) Table 161. Middle East and Africa Microbial Alternative Protein Sales Forecast by Country (2027-2032) & (k units) Table 162. Middle East and Africa Microbial Alternative Protein Sales Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Microbial Alternative Protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Microbial Alternative Protein Market Size by Country (2021-2026) & (US$ Million) Table 165. Middle East and Africa Microbial Alternative Protein Market Share by Country (2021-2026) Table 166. Middle East and Africa Microbial Alternative Protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Middle East and Africa Microbial Alternative Protein Market Share Forecast by Country (2027-2032) Table 168. Key Raw Materials Table 169. Raw Materials Key Suppliers Table 170. Microbial Alternative Protein Distributors List Table 171. Microbial Alternative Protein Customers List Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Microbial Alternative Protein Image Figure 2. Global Microbial Alternative Protein Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Microbial Alternative Protein Market Size (2021-2032) & (US$ Million) Figure 4. Global Microbial Alternative Protein Sales (2021-2032) & (k units) Figure 5. Yeast Protein Image Figure 6. Global Yeast Protein Sales YoY Growth (2021-2032) & (k units) Figure 7. Microalgae Protein Image Figure 8. Global Microalgae Protein Sales YoY Growth (2021-2032) & (k units) Figure 9. Bacterial Protein Image Figure 10. Global Bacterial Protein Sales YoY Growth (2021-2032) & (k units) Figure 11. Other Image Figure 12. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 13. Global Microbial Alternative Protein Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Microbial Alternative Protein Market Share by Type 2025 VS 2032 Figure 15. North America Microbial Alternative Protein Sales Market Share in Volume by Type in 2025 Figure 16. North America Microbial Alternative Protein Sales Market Share in Value by Type in 2025 Figure 17. Europe Microbial Alternative Protein Sales Market Share in Volume by Type in 2025 Figure 18. Europe Microbial Alternative Protein Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Microbial Alternative Protein Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Microbial Alternative Protein Sales Market Share in Value by Type in 2025 Figure 21. Latin America Microbial Alternative Protein Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Microbial Alternative Protein Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Microbial Alternative Protein Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Microbial Alternative Protein Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Microbial Alternative Protein Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Food Image Figure 28. Global Food Sales YoY Growth (2021-2032) & (k units) Figure 29. Feed Image Figure 30. Global Feed Sales YoY Growth (2021-2032) & (k units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 33. Global Microbial Alternative Protein Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Microbial Alternative Protein Market Share by Application 2025 VS 2032 Figure 35. North America Microbial Alternative Protein Sales Market Share in Volume by Application in 2025 Figure 36. North America Microbial Alternative Protein Sales Market Share in Value by Application in 2025 Figure 37. Europe Microbial Alternative Protein Sales Market Share in Volume by Application in 2025 Figure 38. Europe Microbial Alternative Protein Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Microbial Alternative Protein Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Microbial Alternative Protein Sales Market Share in Value by Application in 2025 Figure 41. Latin America Microbial Alternative Protein Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Microbial Alternative Protein Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Microbial Alternative Protein Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Microbial Alternative Protein Sales Market Share in Value by Application in 2025 Figure 45. North America Microbial Alternative Protein Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America Microbial Alternative Protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Microbial Alternative Protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Microbial Alternative Protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Microbial Alternative Protein Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe Microbial Alternative Protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Microbial Alternative Protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Microbial Alternative Protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Microbial Alternative Protein Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific Microbial Alternative Protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Microbial Alternative Protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Microbial Alternative Protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Microbial Alternative Protein Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America Microbial Alternative Protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Microbial Alternative Protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Microbial Alternative Protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Microbial Alternative Protein Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa Microbial Alternative Protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Microbial Alternative Protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Microbial Alternative Protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Microbial Alternative Protein Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Microbial Alternative Protein Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Yeast Protein
  • Microalgae Protein
  • Bacterial Protein
  • Other
Applications
  • Food
  • Feed
  • Others
Companies covered
  • AgriProtein (South Africa)
  • Ynsect (France)
  • Enterra Feed Corporation (Canada)
  • Protix (The Netherlands)
  • Proti-Farm Holding NV (The Netherlands)
  • Entomo Farms (Canada)
  • Global Bugs Asia Co., Ltd. (Thailand)
  • Aspire Food Group (U.S.)
  • Tiny Farms (U.S.)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Microbial Alternative Protein Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Microbial Alternative Protein Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Microbial Alternative Protein Market by Type
  6. 1.3.1 Yeast Protein
  7. 1.3.2 Microalgae Protein
  8. 1.3.3 Bacterial Protein
  9. 1.3.4 Other
  10. 1.4 Global Microbial Alternative Protein Market Size by Type
  11. 1.4.1 Global Microbial Alternative Protein Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Microbial Alternative Protein Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Microbial Alternative Protein Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Microbial Alternative Protein Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Microbial Alternative Protein Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Microbial Alternative Protein Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Microbial Alternative Protein Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Microbial Alternative Protein Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Microbial Alternative Protein Industry Trends
  2. 2.2 Microbial Alternative Protein Industry Drivers
  3. 2.3 Microbial Alternative Protein Industry Opportunities and Challenges
  4. 2.4 Microbial Alternative Protein Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Microbial Alternative Protein Revenue (2021-2026)
  2. 3.2 Global Top Players by Microbial Alternative Protein Sales (2021-2026)
  3. 3.3 Global Top Players by Microbial Alternative Protein Price (2021-2026)
  4. 3.4 Global Microbial Alternative Protein Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Microbial Alternative Protein Major Company Production Sites & Headquarters
  6. 3.6 Global Microbial Alternative Protein Company, Product Type & Application
  7. 3.7 Global Microbial Alternative Protein Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Microbial Alternative Protein Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Microbial Alternative Protein Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Microbial Alternative Protein Tier 1, Tier 2, and Tier 3
4 Microbial Alternative Protein Regional Status and Outlook
  1. 4.1 Global Microbial Alternative Protein Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Microbial Alternative Protein Historic Market Size by Region
  3. 4.2.1 Global Microbial Alternative Protein Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Microbial Alternative Protein Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Microbial Alternative Protein Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Microbial Alternative Protein Forecasted Market Size by Region
  7. 4.3.1 Global Microbial Alternative Protein Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Microbial Alternative Protein Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Microbial Alternative Protein Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Microbial Alternative Protein by Application
  1. 5.1 Microbial Alternative Protein Market by Application
  2. 5.1.1 Food
  3. 5.1.2 Feed
  4. 5.1.3 Others
  5. 5.2 Global Microbial Alternative Protein Market Size by Application
  6. 5.2.1 Global Microbial Alternative Protein Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Microbial Alternative Protein Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Microbial Alternative Protein Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Microbial Alternative Protein Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Microbial Alternative Protein Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Microbial Alternative Protein Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Microbial Alternative Protein Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Microbial Alternative Protein Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 AgriProtein (South Africa)
  2. 6.1.1 AgriProtein (South Africa) Company Information
  3. 6.1.2 AgriProtein (South Africa) Business Overview
  4. 6.1.3 AgriProtein (South Africa) Microbial Alternative Protein Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 AgriProtein (South Africa) Microbial Alternative Protein Product Portfolio
  6. 6.1.5 AgriProtein (South Africa) Recent Developments
  7. 6.2 Ynsect (France)
  8. 6.2.1 Ynsect (France) Company Information
  9. 6.2.2 Ynsect (France) Business Overview
  10. 6.2.3 Ynsect (France) Microbial Alternative Protein Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Ynsect (France) Microbial Alternative Protein Product Portfolio
  12. 6.2.5 Ynsect (France) Recent Developments
  13. 6.3 Enterra Feed Corporation (Canada)
  14. 6.3.1 Enterra Feed Corporation (Canada) Company Information
  15. 6.3.2 Enterra Feed Corporation (Canada) Business Overview
  16. 6.3.3 Enterra Feed Corporation (Canada) Microbial Alternative Protein Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Enterra Feed Corporation (Canada) Microbial Alternative Protein Product Portfolio
  18. 6.3.5 Enterra Feed Corporation (Canada) Recent Developments
  19. 6.4 Protix (The Netherlands)
  20. 6.4.1 Protix (The Netherlands) Company Information
  21. 6.4.2 Protix (The Netherlands) Business Overview
  22. 6.4.3 Protix (The Netherlands) Microbial Alternative Protein Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Protix (The Netherlands) Microbial Alternative Protein Product Portfolio
  24. 6.4.5 Protix (The Netherlands) Recent Developments
  25. 6.5 Proti-Farm Holding NV (The Netherlands)
  26. 6.5.1 Proti-Farm Holding NV (The Netherlands) Company Information
  27. 6.5.2 Proti-Farm Holding NV (The Netherlands) Business Overview
  28. 6.5.3 Proti-Farm Holding NV (The Netherlands) Microbial Alternative Protein Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Proti-Farm Holding NV (The Netherlands) Microbial Alternative Protein Product Portfolio
  30. 6.5.5 Proti-Farm Holding NV (The Netherlands) Recent Developments
  31. 6.6 Entomo Farms (Canada)
  32. 6.6.1 Entomo Farms (Canada) Company Information
  33. 6.6.2 Entomo Farms (Canada) Business Overview
  34. 6.6.3 Entomo Farms (Canada) Microbial Alternative Protein Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Entomo Farms (Canada) Microbial Alternative Protein Product Portfolio
  36. 6.6.5 Entomo Farms (Canada) Recent Developments
  37. 6.7 Global Bugs Asia Co., Ltd. (Thailand)
  38. 6.7.1 Global Bugs Asia Co., Ltd. (Thailand) Company Information
  39. 6.7.2 Global Bugs Asia Co., Ltd. (Thailand) Business Overview
  40. 6.7.3 Global Bugs Asia Co., Ltd. (Thailand) Microbial Alternative Protein Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Global Bugs Asia Co., Ltd. (Thailand) Microbial Alternative Protein Product Portfolio
  42. 6.7.5 Global Bugs Asia Co., Ltd. (Thailand) Recent Developments
  43. 6.8 Aspire Food Group (U.S.)
  44. 6.8.1 Aspire Food Group (U.S.) Company Information
  45. 6.8.2 Aspire Food Group (U.S.) Business Overview
  46. 6.8.3 Aspire Food Group (U.S.) Microbial Alternative Protein Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Aspire Food Group (U.S.) Microbial Alternative Protein Product Portfolio
  48. 6.8.5 Aspire Food Group (U.S.) Recent Developments
  49. 6.9 Tiny Farms (U.S.)
  50. 6.9.1 Tiny Farms (U.S.) Company Information
  51. 6.9.2 Tiny Farms (U.S.) Business Overview
  52. 6.9.3 Tiny Farms (U.S.) Microbial Alternative Protein Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Tiny Farms (U.S.) Microbial Alternative Protein Product Portfolio
  54. 6.9.5 Tiny Farms (U.S.) Recent Developments
7 North America by Country
  1. 7.1 North America Microbial Alternative Protein Sales by Country
  2. 7.1.1 North America Microbial Alternative Protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Microbial Alternative Protein Sales by Country (2021-2026)
  4. 7.1.3 North America Microbial Alternative Protein Sales Forecast by Country (2027-2032)
  5. 7.2 North America Microbial Alternative Protein Market Size by Country
  6. 7.2.1 North America Microbial Alternative Protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Microbial Alternative Protein Market Size by Country (2021-2026)
  8. 7.2.3 North America Microbial Alternative Protein Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Microbial Alternative Protein Sales by Country
  2. 8.1.1 Europe Microbial Alternative Protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Microbial Alternative Protein Sales by Country (2021-2026)
  4. 8.1.3 Europe Microbial Alternative Protein Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Microbial Alternative Protein Market Size by Country
  6. 8.2.1 Europe Microbial Alternative Protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Microbial Alternative Protein Market Size by Country (2021-2026)
  8. 8.2.3 Europe Microbial Alternative Protein Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Microbial Alternative Protein Sales by Country
  2. 9.1.1 Asia-Pacific Microbial Alternative Protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Microbial Alternative Protein Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Microbial Alternative Protein Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Microbial Alternative Protein Market Size by Country
  6. 9.2.1 Asia-Pacific Microbial Alternative Protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Microbial Alternative Protein Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Microbial Alternative Protein Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Microbial Alternative Protein Sales by Country
  2. 10.1.1 South America Microbial Alternative Protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Microbial Alternative Protein Sales by Country (2021-2026)
  4. 10.1.3 South America Microbial Alternative Protein Sales Forecast by Country (2027-2032)
  5. 10.2 South America Microbial Alternative Protein Market Size by Country
  6. 10.2.1 South America Microbial Alternative Protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Microbial Alternative Protein Market Size by Country (2021-2026)
  8. 10.2.3 South America Microbial Alternative Protein Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Microbial Alternative Protein Sales by Country
  2. 11.1.1 Middle East and Africa Microbial Alternative Protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Microbial Alternative Protein Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Microbial Alternative Protein Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Microbial Alternative Protein Market Size by Country
  6. 11.2.1 Middle East and Africa Microbial Alternative Protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Microbial Alternative Protein Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Microbial Alternative Protein Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Microbial Alternative Protein Value Chain Analysis
  2. 12.1.1 Microbial Alternative Protein Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Microbial Alternative Protein Production Mode & Process
  7. 12.2 Microbial Alternative Protein Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Microbial Alternative Protein Distributors
  10. 12.2.3 Microbial Alternative Protein Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst